Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
The Journal of Urology
|
December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical Experience
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans
Yong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
The Journal of Urology
|
April 9, 2026
Reply by Authors
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT
Felicia Wang, Chen Liu, Igor Vidal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Breast (Edinburgh, Scotland)
|
March 6, 2025
A composite <sup>18</sup>F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, et al.
JCO Precision Oncology
|
April 3, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
The Journal of Urology
|
December 23, 2025
Performance of <sup>99m</sup>Tc-sestamibi SPECT/CT for Characterizing Renal Masses: Combined Results from a Prospective Scan-and-Resect Trial and Clinical Experience
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
[<sup>18</sup>F]FNDP PET neuroimaging test-retest repeatability and whole-body dosimetry in humans
Yong Du, Jennifer M Coughlin, Alireza Amindarolzarbi, et al.
The Journal of Urology
|
April 9, 2026
Reply by Authors
Steven P Rowe, Salikh Murtazaliev, Alireza Amindarolzarbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT
Felicia Wang, Chen Liu, Igor Vidal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 24, 2025
Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Lena M Unterrainer, Nicolas De Leiris, Marcus Unterrainer, et al.
Breast (Edinburgh, Scotland)
|
March 6, 2025
A composite <sup>18</sup>F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, et al.
JCO Precision Oncology
|
April 3, 2025
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response
Maeve A Hennessy, Ashley Cimino-Mathews, Jodi M Carter, et al.
Page
of 12